Main Article Content
Background. The problem of the prevalence of comorbid pathology among patients is becoming increasingly relevant. In comorbidity, certain diseases become atypical with increased risk of complications and the problem of polypragmasia, and patients’ adherence to treatment decreases. The purpose was to study the structure and frequency of concomitant endocrine pathology in patients with type 2 diabetes mellitus (DM) and its impact on treatment effectiveness. Materials and methods. The study involved 2,264 patients with type 2 DM (1,186 men and 1,078 women) who have received medical care at the Ukrainian Research and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues for the last 5 years. We have studied the frequency and structure of concomitant endocrine pathology in patients with type 2 DM, depending on the place of their residence, duration of type 2 DM, body mass index, the level of glycated hemoglobin (HbA1c), medical approaches, the presence of myocardial infarction (MI), stroke and diabetic foot syndrome. Results. HbA1c level in patients of both sexes, MI and stroke in men do not have a significant effect on the frequency of other endocrine pathology in patients with type 2 DM; on the contrary, area of residence, body mass index and diabetic foot syndrome in patients of both sexes have a significant effect, and duration of type 2 DM in patients of both sexes, MI and stroke in women have a moderate influence, which requires consideration when managing patients with type 2 DM. The incidence of other endocrine pathology grows with increasing BMI: in men — by 1.4 times, in women — by 1.3 times. The presence of another endocrine pathology in type 2 DM patients does not have a significant impact on the effectiveness of DM treatment. Conclusions. Further researches are needed to study the mechanisms underlying the significantly lower incidence of other endocrine pathology in patients with diabetic foot syndrome, the significantly higher incidence of other endocrine pathology in women, the absence of diffuse goiter in women with MI and stroke, isolated cases in men with MI and stroke, as well as a higher incidence of primary hyperparathyroidism in patients with type 2 DM and MI.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Chiang JI, Jani BD, Mair FS, et al. Associations between multimorbidity, all-cause mortality and glycaemia in people with type 2 diabetes: A systematic review. PLoS One. 2018 Dec 26;13(12):e0209585. doi: 10.1371/journal.pone.0209585.
International Diabetes Federation. IDF Diabetes Atlas. 8th Edition. 2017. Available from: https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/134-idf-diabetes-atlas-8th-edition.html.
Diederichs C, Berger K, Bartels DB. The measurement of multiple chronic diseases – a systematic review on existing multimorbidity indices. J Gerontol A Biol Sci Med Sci. 2011 Mar;66(3):301-11. doi: 10.1093/gerona/glq208.
Abbatecola AM, Bo M, Barbagallo M, et al. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study. J Am Med Dir Assoc. 2015 Apr;16(4):349.e7-12. doi: 10.1016/j.jamda.2014.12.014.
Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009 Jul-Aug;7(4):357-63. doi: 10.1370/afm.983.
Schafer I, Hansen H, Schon G, et al. The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. First results from the multicare cohort study. BMC Health Serv Res. 2012 Apr 3;12:89. doi: 10.1186/1472-6963-12-89.
Baldwin LM, Klabunde CN, Green P, Barlow W, Wright G. In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care. 2006 Aug;44(8):745-53. doi: 10.1097/01.mlr.0000223475.70440.07.
Lee DS, Donovan L, Austin PC, et al. Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care. 2005 Feb;43(2):182-8. doi: 10.1097/00005650-200502000-00012.
Lash TL, Mor V, Wieland D, Ferrucci L, Satariano W, Silliman RA. Methodology, design, and analytic techniques to address measurement of comorbid disease. J Gerontol A Biol Sci Med Sci. 2007 Mar;62(3):281-5. doi: 10.1093/gerona/62.3.281.
Oganov RG, Denisov IN, Simanenkov VI, et al. Comorbid pathology in clinical practice. Clinical recommendations. Cardiovascular Therapy and Prevention. 2017;16(6):5-56. (in Russian). doi: 10.15829/1728-8800-2017-6-5-56.